A comparison of comorbidity measures for predicting mortality after elective hip and knee replacement: A cohort study of data from the National Joint Registry in England and Wales.

<h4>Background</h4>The risk of mortality following elective total hip (THR) and knee replacements (KR) may be influenced by patients' pre-existing comorbidities. There are a variety of scores derived from individual comorbidities that can be used in an attempt to quantify this. The...

Full description

Saved in:
Bibliographic Details
Main Authors: Chris M Penfold, Michael R Whitehouse, Ashley W Blom, Andrew Judge, J Mark Wilkinson, Adrian Sayers
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0255602&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849469175882317824
author Chris M Penfold
Michael R Whitehouse
Ashley W Blom
Andrew Judge
J Mark Wilkinson
Adrian Sayers
author_facet Chris M Penfold
Michael R Whitehouse
Ashley W Blom
Andrew Judge
J Mark Wilkinson
Adrian Sayers
author_sort Chris M Penfold
collection DOAJ
description <h4>Background</h4>The risk of mortality following elective total hip (THR) and knee replacements (KR) may be influenced by patients' pre-existing comorbidities. There are a variety of scores derived from individual comorbidities that can be used in an attempt to quantify this. The aims of this study were to a) identify which comorbidity score best predicts risk of mortality within 90 days or b) determine which comorbidity score best predicts risk of mortality at other relevant timepoints (30, 45, 120 and 365 days).<h4>Patients and methods</h4>We linked data from the National Joint Registry (NJR) on primary elective hip and knee replacements performed between 2011-2015 with pre-existing conditions recorded in the Hospital Episodes Statistics. We derived comorbidity scores (Charlson Comorbidity Index-CCI, Elixhauser, Hospital Frailty Risk Score-HFRS). We used binary logistic regression models of all-cause mortality within 90-days and within 30, 45, 120 and 365-days of the primary operation using, adjusted for age and gender. We compared the performance of these models in predicting all-cause mortality using the area under the Receiver-operator characteristics curve (AUROC) and the Index of Prediction Accuracy (IPA).<h4>Results</h4>We included 276,594 elective primary THRs and 338,287 elective primary KRs for any indication. Mortality within 90-days was 0.34% (N = 939) after THR and 0.26% (N = 865) after KR. The AUROC for the CCI and Elixhauser scores in models of mortality ranged from 0.78-0.81 after THR and KR, which slightly outperformed models with ASA grade (AUROC = 0.77-0.78). HFRS performed similarly to ASA grade (AUROC = 0.76-0.78). The inclusion of comorbidities prior to the primary operation offers no improvement beyond models with comorbidities at the time of the primary. The discriminative ability of all prediction models was best for mortality within 30 days and worst for mortality within 365 days.<h4>Conclusions</h4>Comorbidity scores add little improvement beyond simpler models with age, gender and ASA grade for predicting mortality within one year after elective hip or knee replacement. The additional patient-specific information required to construct comorbidity scores must be balanced against their prediction gain when considering their utility.
format Article
id doaj-art-a2d2bd0c8e564e8c9702a6247014d01f
institution Kabale University
issn 1932-6203
language English
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-a2d2bd0c8e564e8c9702a6247014d01f2025-08-20T03:25:35ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01168e025560210.1371/journal.pone.0255602A comparison of comorbidity measures for predicting mortality after elective hip and knee replacement: A cohort study of data from the National Joint Registry in England and Wales.Chris M PenfoldMichael R WhitehouseAshley W BlomAndrew JudgeJ Mark WilkinsonAdrian Sayers<h4>Background</h4>The risk of mortality following elective total hip (THR) and knee replacements (KR) may be influenced by patients' pre-existing comorbidities. There are a variety of scores derived from individual comorbidities that can be used in an attempt to quantify this. The aims of this study were to a) identify which comorbidity score best predicts risk of mortality within 90 days or b) determine which comorbidity score best predicts risk of mortality at other relevant timepoints (30, 45, 120 and 365 days).<h4>Patients and methods</h4>We linked data from the National Joint Registry (NJR) on primary elective hip and knee replacements performed between 2011-2015 with pre-existing conditions recorded in the Hospital Episodes Statistics. We derived comorbidity scores (Charlson Comorbidity Index-CCI, Elixhauser, Hospital Frailty Risk Score-HFRS). We used binary logistic regression models of all-cause mortality within 90-days and within 30, 45, 120 and 365-days of the primary operation using, adjusted for age and gender. We compared the performance of these models in predicting all-cause mortality using the area under the Receiver-operator characteristics curve (AUROC) and the Index of Prediction Accuracy (IPA).<h4>Results</h4>We included 276,594 elective primary THRs and 338,287 elective primary KRs for any indication. Mortality within 90-days was 0.34% (N = 939) after THR and 0.26% (N = 865) after KR. The AUROC for the CCI and Elixhauser scores in models of mortality ranged from 0.78-0.81 after THR and KR, which slightly outperformed models with ASA grade (AUROC = 0.77-0.78). HFRS performed similarly to ASA grade (AUROC = 0.76-0.78). The inclusion of comorbidities prior to the primary operation offers no improvement beyond models with comorbidities at the time of the primary. The discriminative ability of all prediction models was best for mortality within 30 days and worst for mortality within 365 days.<h4>Conclusions</h4>Comorbidity scores add little improvement beyond simpler models with age, gender and ASA grade for predicting mortality within one year after elective hip or knee replacement. The additional patient-specific information required to construct comorbidity scores must be balanced against their prediction gain when considering their utility.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0255602&type=printable
spellingShingle Chris M Penfold
Michael R Whitehouse
Ashley W Blom
Andrew Judge
J Mark Wilkinson
Adrian Sayers
A comparison of comorbidity measures for predicting mortality after elective hip and knee replacement: A cohort study of data from the National Joint Registry in England and Wales.
PLoS ONE
title A comparison of comorbidity measures for predicting mortality after elective hip and knee replacement: A cohort study of data from the National Joint Registry in England and Wales.
title_full A comparison of comorbidity measures for predicting mortality after elective hip and knee replacement: A cohort study of data from the National Joint Registry in England and Wales.
title_fullStr A comparison of comorbidity measures for predicting mortality after elective hip and knee replacement: A cohort study of data from the National Joint Registry in England and Wales.
title_full_unstemmed A comparison of comorbidity measures for predicting mortality after elective hip and knee replacement: A cohort study of data from the National Joint Registry in England and Wales.
title_short A comparison of comorbidity measures for predicting mortality after elective hip and knee replacement: A cohort study of data from the National Joint Registry in England and Wales.
title_sort comparison of comorbidity measures for predicting mortality after elective hip and knee replacement a cohort study of data from the national joint registry in england and wales
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0255602&type=printable
work_keys_str_mv AT chrismpenfold acomparisonofcomorbiditymeasuresforpredictingmortalityafterelectivehipandkneereplacementacohortstudyofdatafromthenationaljointregistryinenglandandwales
AT michaelrwhitehouse acomparisonofcomorbiditymeasuresforpredictingmortalityafterelectivehipandkneereplacementacohortstudyofdatafromthenationaljointregistryinenglandandwales
AT ashleywblom acomparisonofcomorbiditymeasuresforpredictingmortalityafterelectivehipandkneereplacementacohortstudyofdatafromthenationaljointregistryinenglandandwales
AT andrewjudge acomparisonofcomorbiditymeasuresforpredictingmortalityafterelectivehipandkneereplacementacohortstudyofdatafromthenationaljointregistryinenglandandwales
AT jmarkwilkinson acomparisonofcomorbiditymeasuresforpredictingmortalityafterelectivehipandkneereplacementacohortstudyofdatafromthenationaljointregistryinenglandandwales
AT adriansayers acomparisonofcomorbiditymeasuresforpredictingmortalityafterelectivehipandkneereplacementacohortstudyofdatafromthenationaljointregistryinenglandandwales
AT chrismpenfold comparisonofcomorbiditymeasuresforpredictingmortalityafterelectivehipandkneereplacementacohortstudyofdatafromthenationaljointregistryinenglandandwales
AT michaelrwhitehouse comparisonofcomorbiditymeasuresforpredictingmortalityafterelectivehipandkneereplacementacohortstudyofdatafromthenationaljointregistryinenglandandwales
AT ashleywblom comparisonofcomorbiditymeasuresforpredictingmortalityafterelectivehipandkneereplacementacohortstudyofdatafromthenationaljointregistryinenglandandwales
AT andrewjudge comparisonofcomorbiditymeasuresforpredictingmortalityafterelectivehipandkneereplacementacohortstudyofdatafromthenationaljointregistryinenglandandwales
AT jmarkwilkinson comparisonofcomorbiditymeasuresforpredictingmortalityafterelectivehipandkneereplacementacohortstudyofdatafromthenationaljointregistryinenglandandwales
AT adriansayers comparisonofcomorbiditymeasuresforpredictingmortalityafterelectivehipandkneereplacementacohortstudyofdatafromthenationaljointregistryinenglandandwales